NDRG2 expressions were analyzed in urine samples of 127 patients with bladder cancer and 97 healthy controls and in bladder cancer cell lines by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blotting. The gene discussed is NDRG2; the disease is urinary bladder carcinoma.